Ives Jeffrey L. 4
4 · Acumen Pharmaceuticals, Inc. · Filed Jun 10, 2024
Insider Transaction Report
Form 4
Ives Jeffrey L.
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-10+25,000→ 25,000 totalExercise: $2.62Exp: 2034-06-09→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of June 10, 2025 or the 2025 annual stockholder meeting, subject to the Reporting Person's continuous service through each such vesting date.